Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer

Japanese Journal of Clinical Oncology

Volumn 38, Issue 8, 2008, Pages 567-570

  Ono, Makiko ^a   Watanabe, Takashi ^a   Shimizu, Chikako ^a   Hiramoto, Nobuhiro ^a   Goto, Yasushi ^a   Yonemori, Kan ^a   Kouno, Tsutomu ^a   Ando, Masashi ^a   Tamura, Kenji ^a   Katsumata, Noriyuki ^a   Fujiwara, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

All trans retinoic acid; Breast conserving surgery; Radiation; Secondary leukemia; Tamoxifen

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CYTARABINE; DAUNORUBICIN; GONADORELIN DERIVATIVE; HORMONE; HORMONE RECEPTOR; IDARUBICIN; MEDROXYPROGESTERONE ACETATE; MITOXANTRONE; PACLITAXEL; RETINOIC ACID; TAMOXIFEN;

ADULT; ARTICLE; BONE MARROW BIOPSY; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; FEMALE; FEMALE FERTILITY; FEVER; GINGIVA BLEEDING; HUMAN; JAPANESE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHADENOPATHY; PAGET NIPPLE DISEASE; PANCYTOPENIA; PARTIAL MASTECTOMY; PERIPHERAL EDEMA; PROMYELOCYTIC LEUKEMIA; RECURRENT CANCER; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; LEUKEMIA; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SECOND CANCER; TUMOR RECURRENCE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKEMIA, RADIATION-INDUCED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY;

EID: 51649104987     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn057     Document Type: Article

References (21)

1. Pagano L, Pulsoni A, Tosti ME, Avvisati G, Mele L, Mele A, et al. Clinical and biological features of acute myeloid leukemia occurring as second malignancy: GIMEMA archive of adult acute leukemia. Br J Haematol 2001;112:109-17.
2. Fisher B, Rockette H, Fisher ER, Wickerham L, Redmond C, Brown A. Leukemia in breast cancer patients following adjuvant chemotherapy or post-operative radiation. J Clin Oncol 1985;3:1640-58.
3. Smith RE, Bryant J, DeCillis A, Anderson S. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol 2003; 21:1195-2041
4. Ando M, Narabayashi M, Watanabe T, Kamiya Y, Togitani K, Tanosaki R, et al. Therapy-related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide or anthracyclines. Jpn J Clin Oncol 1999;29:28-32.
5. Curtis RE, Boice JD, Stovall M, Bernstein L, Greenberg RS, Flannery J, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745-51.
6. Ratain MJ, Rowley JD. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: From the bedside to the target genes. Ann Oncol 1992;3:107-11.
7. Chaplain G, Milan C, Sgro C, Carli PM, Bonithon-Kopp C, et al. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: A population-based study. J Clin Oncol 2000;18:2836-42.
8. Yalcin S, Gullu I, Demiroglu H, Tekuzman G. Acute leukemia during tamoxifen therapy. Med Oncol 1997;14:61-2.
9. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 1995;87:645-51.
10. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 1998;351: 1451-67.
11. Haas JF, Kittelmann B, Mehnert WH, Staneczek W, Mohner M, Kaldor JM, et al. Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br J Cancer 1987;55:213-8.
12. Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 2001;51:679-90.
13. Curtis RE, Boice JD, Stovall M, Flannery JT, Moloney WC. Leukemia risk following radiotherapy for breast cancer. J Clin Oncol 1999;7:21-9.
14. Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinet B, et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med 2005;352:1529-38.
15. Matsuyama Y, Tominaga T, Nomura Y, Koyama H, Kimura M, Sano M, et al. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol 2000;11:1537-43.
16. Detourmignies L, Castaigne S, Stoppa AM, Harousseau JL, Sadoun A, Janvier M, et al. Therapy-related acute promyelocytic leukemia: A report on 16 cases. J Clin Oncol 1992;10:1430-5.
17. Kantarjian HM, Keating MJ, Walters RS, Beran M, Mclaughlin P, Mccredie KB, et al. The association of specific "favorable" cytogenetic abnormalities with secondary leukemia. Cancer 1986;58:924-7.
18. Marty M, Genem G, Fischer J, Flandrin G, Berger R, Schaison G, et al. Acute promyelocytic leukemia: Retrospective study of 119 patients treated with daunorubicin. Nouv Rev Fr Hematol 1984;26:371-8.
19. Beaumont M, Sanz M, Carli PM, Thomas MX, Detourmignies L, Guerci A, et al. Therapy-related acute promyelocytic leukemia. J Clin Oncol 2003;21:2123-37. 20 Bhavnani M, Azzawi SA, Yin JA, Lucas GS. Therapy-related acute promyelocytic leukaemia. Br J Haematol 1994;86:231-2.
20. Pollicardo N, O'Brien S, Estey EH, al-Bitar M, Pierce S, Keating M, et al. Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution. Leukemia 1996; 10:27-31.
21. Ades L, Sanz MA, Chevret S, Montesinos P, Chevallier P, Raffoux E, et al. Treatment of newly diagnosed acute promyelocytic leukemia (APL): A comparison of French-Belgian-Swiss and PETHEMA results. Blood 2008;111:1078-84.